Results of a multicenter observational program to evaluate the effectiveness of complex therapy of patients with chronic cerebrovascular pathology with cognitive impairment with Cortexin and Neuromexol (CORNELia study)
Observational study · 2023
- What was studied
- CORNELia; 801 patients with chronic cerebral ischemia and cognitive impairment
- Main finding
- Reports clinical changes with Cortexin plus Neuromexol; biomarkers were assessed in smaller comparison subgroups.
Reported findings and study design
801 chronic-ischemia patients, ages 30–80: 329 men and 472 women. Biomarker subset 30 combination-treated versus 30 comparison patients. Cortexin 10 mg/day for ten days plus Neuromexol 375–750 mg/day for 30 days.
Population or model CORNELia; 801 patients with chronic cerebral ischemia and cognitive impairment
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| NSE biomarker change | Twofold decrease in combination-treated subset | p<0.05 |
| MMSE and drawing-test correlation | r=0.5 before and r=0.6 after treatment | p<0.05 |
| Anti-NR2 antibodies | Decreased in both groups | p<0.05 |
| VEGFA | Decreased only in combination-treated subset | p<0.05 |
Biomarker comparisons use the 30/30 subset, not all 801 patients; treatment combines two drugs.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Combination treatment does not isolate Cortexin’s contribution.
- The biomarker subset is not the full cohort; observational findings do not establish causality.
Source details
Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.
Sources checked
Citation
Mashin VV, Belova LA, Kotova EY, Dolgova DR, Statenina AP, Belyaeva YK, Dergacheva AS, Israfilova RR. Results of a multicenter observational program to evaluate the effectiveness of complex therapy of patients with chronic cerebrovascular pathology with cognitive impairment with Cortexin and Neuromexol (CORNELia study) Zh Nevrol Psikhiatr Im S S Korsakova 123(12):34-41. PMID 38147380
Study source ↗ · DOI 10.17116/jnevro202312312134 · Bibliography entry · Link to this summary